Predictive Medicine: How DNA Testing Is Influencing Healthcare

Will genetic testing and whole genome sequencing become part of the standard of care in treating patients?

Anti-COVID Monoclonal Cocktails

Newly created treatments for high-risk COVID-19 patients have proved highly effective. Unfortunately, challenges with their distribution and administration have limited their use.

Multisystem Inflammatory Syndrome in Children: A Complication of COVID-19

Much remains to be learned about this new condition affecting a growing number of children. However, it is hoped with increased vaccination and fewer cases of the SARS-CoV-2 virus, case numbers of MIS-C will also go down.

Hemophilia Gene Therapy: Cures May Finally Be at Hand

The decades-old dream is to correct the factor deficiency through a single infusion of a hemophilia gene therapy that produces steady high protective levels of FVIII or FIX.

A Brief History of Immunity and Immunoglobulins

Discoveries about the types of immunity eventually led to the use of human antibodies to treat disease.

Against the Storm: High-Dose IVIG as an Immunoregulatory Treatment Strategy for Severe COVID-19

While there may be no “magic bullet” to treat cytokine storm, one widely used immunomodulatory agent in particular — polyclonal intravenous immune globulin (IVIG) purified from healthy donor plasma — is distinguished by the simple fact that it is anything but a narrowly targeted treatment.

Myths & Facts: Childhood Vaccines

Despite proof of lifesaving benefits of vaccines, parental hesitancy to immunizing their children is often fueled by the plethora of myths surrounding vaccine safety.

New Vaccines in Development

Beyond COVID-19 vaccines, research is showing potential for new vaccines to treat several other diseases.

COVID-19 Vaccines: Where Are We Now?

With three vaccines in circulation and three more on the horizon, is the end of the COVID-19 pandemic in sight?

Emerging Novel Viruses

With trillions of viruses living in the human and other species’ microbiomes, the possibility of novel viruses such as COVID-19 emerging is high, but the threat they may pose is unknown.